BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease

被引：0
|
作者：
Poewe, W.
Kieburtz, K.
Stocchi, F.
Oren, S.
Yardeni, T.
Adar, L.
Rosenfeld, O.
Olanow, C.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
179
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study
    Patel, Jayshree C.
    Patel, Parvati B.
    Acharya, Hemangini
    Nakum, Kanaklata
    Tripathi, C. B.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 188 : 118 - 123
  • [42] Design of a randomized, double-blind, double-dummy, placebo-controlled study of levodopa-carbidopa intestinal gel in patients currently receiving optimized treatment for advanced Parkinson's disease
    Olanow, C. W.
    Chatamra, K.
    Benesh, J.
    Pritchett, Y. L.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2011, 26 : S137 - S137
  • [43] Raloxifene and Tibolone in Elderly Women: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial
    Jacobsen, Didy E.
    Melis, Rene J. F.
    Verhaar, Harald J. J.
    Rikkert, Marcel G. M. Olde
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2012, 13 (02) : 189.e1 - 189.e7
  • [44] A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum
    Villahermosa, LG
    Fajardo, TT
    Abalos, RM
    Balagon, MV
    Tan, EV
    Cellona, RV
    Palmer, JP
    Wittes, J
    Thomas, SD
    Kook, KA
    Walsh, GP
    Walsh, DS
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (05): : 518 - 526
  • [45] Erenumab versus topiramate for the prevention of migraine: Results of a randomized active-controlled double-dummy trial
    Reuter, U.
    Ehrlich, M.
    Gendolla, A.
    Heinze, A.
    Klatt, J.
    Wen, S.
    Hours-Zesiger, P.
    Nickisch, J.
    Sieder, C.
    Hentschke, C.
    Maier-Peuschel, M.
    HEADACHE, 2021, 61 : 174 - 175
  • [46] Subgroup Analyses of a Phase 3 Randomized Study of Levodopa/Carbidopa Infusion (ND0612) for Parkinson's Patients
    Poewe, W.
    Espay, A.
    Lopes, N.
    Ferreira, J.
    MOVEMENT DISORDERS, 2024, 39 : S306 - S306
  • [47] VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis
    Schreiber, Stefan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S612 - S613
  • [48] Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
    Vecchi, M
    Meucci, G
    Gionchetti, P
    Beltrami, M
    Di Maurizio, P
    Beretta, L
    Ganio, E
    Usai, P
    Campieri, M
    Fornaciari, G
    De Franchis, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) : 251 - 256
  • [49] Cardiac safety profile of nebulized formoterol in adults with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Nelson, Harold S.
    Gross, Nicholas J.
    Levine, Bernard
    Kerwin, Edward M.
    Rinehart, Mike
    Denis-Mize, Kimberly
    CLINICAL THERAPEUTICS, 2007, 29 (10) : 2167 - 2178
  • [50] Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S85 - S86
12345